Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Endovascular Thrombectomy Plus Medical Management Versus Medical Management Alone in Acute Ischemic Stroke Patients With Large Vessel Occlusion and Extra-Large Infarct Core: A Multicenter, Randomized Controlled Trial

NCT06388148 is registered in ClinicalTrials.gov with Zhongming Qiu as lead sponsor.

NCT NCT06388148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06388148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Endovascular Thrombectomy Plus Medical Management Versus Medical Management Alone in Acute Ischemic Stroke Patients With Large Vessel Occlusion and Extra-Large Infarct Core: A Multicenter, Randomized Controlled Trial
Lead sponsor
Zhongming Qiu
Phase
Not applicable
Overall status
Recruiting
Start date
June 16, 2024
Completion date
January 31, 2027
Enrollment
286 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute ischemic